Inflammatory intermediaries in inflammatory bowel disease
- 1 June 1989
- journal article
- review article
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 4 (2) , 75-90
- https://doi.org/10.1007/bf01646865
Abstract
No abstract availableThis publication has 150 references indexed in Scilit:
- Increased arachidonic acid composition of phospholipids in colonic mucosa from patients with active ulcerative colitis.Gut, 1987
- The antiinflammatory moiety of sulfasalazine, 5-aminosalicylic acid, is a radical scavengerInflammation Research, 1987
- Topical 5-aminosalicylic acid versus prednisolone in ulcerative proctosigmoiditisDigestive Diseases and Sciences, 1987
- Inhibition of 5-lipoxygenase pathway of arachidonic acid metabolism in human neutrophils by sulfasalazine and 5-aminosalicylic acidDigestive Diseases and Sciences, 1987
- Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseasesDigestive Diseases and Sciences, 1987
- Oxygen-Derived Free Radicals in Postischemic Tissue InjuryNew England Journal of Medicine, 1985
- Pharmacology of kinins: Their relevance to tissue injury and inflammationGeneral Pharmacology: The Vascular System, 1983
- Recent Developments in Nonspecific Inflammatory Bowel DiseaseNew England Journal of Medicine, 1982
- Studies of prostaglandins and sulphasalazine in ulcerative colitisProstaglandins and Medicine, 1981
- The Alternative Pathway of Complement — A System for Host Resistance to Microbial InfectionNew England Journal of Medicine, 1980